Global Antibacterial Drugs Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
Published Date: Dec 2021
No. of Pages: 150
Status: Published
Report Code: ARI101000
Antibacterial Drugs Market is valued around USD 45864.58 Million in 2017 and expected to reach USD 50204.61 Million by 2024 with the CAGR of 1.3% over the forecast period. Increased prevalence of infectious disease and increased demand for efficient antibacterial drugs is the key drivers for Global Antibacterial Drugs Market Antibacterial Drugs market report published by the Analytical Research Insights Pvt. Ltd. provides the detail information about antibacterial drugs market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with drug class, route of administration, distribution channel. Antibacterial drugs are those drugs which can kill or inhibit the growth of microorganism such as bacteria, virus, fungi and others. Antibacterial drugs are mostly used for the treatment of prevention of infectious disease caused due to such microorganisms. There are different classes of antibacterial drugs available in the market according to the microorganisms. Antibiotics are widely being used in the healthcare practices apart from treating chronic infections they are used in medical procedures such as organ transplantation, chemotherapy and surgical operations. These procedures carry high risk of chronic bacterial infection due to which antibacterial drugs are in great demand. The global antibacterial drugs market has also been impacted by several new drugs launched in the market these novel antibiotics act as an insurance mechanism against the future impact of resistance.
There are various factors driving the growth of the antibacterial drugs market, one of the major driving the growth of the market is increased prevalence of infectious disease over the period of time. As per Centers for Disease Control and Prevention 2017 report, around 16.8 million people in the U.S. visit physician office due to the infectious and parasitic diseases. Furthermore, geriatric population is more prone to infectious disease due to the weak immune system and growing geriatric population is expected to fuel the growth of antibacterial drugs market. Moreover, increased demand of efficient antibacterial drugs is also expected to support the growth of antibacterial drugs market. Increase in antibacterial resistance and increasing demand for novel drugs are expected to promote the growth of antibacterial drugs market. However, increase use of generic drugs patent expiry is expected inhibit the growth of antibacterial drugs market over the forecast period.
Antibacterial Drugs Market Key Players:
Pfizer Inc.
Sanofi
GlaxoSmithKline Plc.
Allergen Plc.
Novartis Ag
AstraZeneca
Bayer AG
Merck & Co. Inc.
Other
Antibacterial Drugs Market Segmentation:
By Drug Class
B-lactams
Quinolones
Macrolides
Tetracycline
Aminoglycoside
Others
By Route of Administration
Enteral
Parenteral
Others
By Distribution Channel
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Sales
By Region
North America - US, Mexico, Chile, Canada
Europe - UK, France, Germany, Italy
Asia Pacific - China, South Korea, Japan, India, Southeast Asia
Latin America - Brazil
Middle East and Africa - GCC, Africa, Rest of Middle East and Africa
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. Enteral Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Antibacterial Drugs Market
Chapter 5. Global Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
5.1. Global Antibacterial Drugs Market Share, By Drug Class, 2015 - 2028 (USD Million)
5.1.1. B-lactams
5.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.2. Quinolones
5.1.2.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.3. Macrolides
5.1.3.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.4. Tetracycline
5.1.4.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.5. Aminoglycoside
5.1.5.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.6. Other
5.1.6.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.6.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 6. Global Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
6.1. Global Antibacterial Drugs Market Share, By Route of Administration, 2015 - 2028 (USD Million)
6.1.1. Enteral
6.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.2. Parenteral
6.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.3. Other
6.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 7. Global Antibacterial Drugs Market Overview, By Distribution Channel, 2015 - 2028(USD Million)
7.1. Global Antibacterial Drugs Market Share, By Distribution Channel, 2015 - 2028 (USD Million)
7.1.1. Hospital Pharmacies
7.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.2. Drug Stores and Retail Pharmacies
7.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.3. Other
7.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 8. Global Antibacterial Drugs Market Overview, By Geography, 2015 - 2028(USD Million)
8.1. Global Antibacterial Drugs Market Share, By Geography, 2015 - 2028(USD Million)
8.1.1. Market Size and projections, by Countries, 2015 - 2028 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2028 (%)
Chapter 9. North America Antibacterial Drugs Market Overview, By Countries, 2015 - 2028(USD Million)
9.1. North America Antibacterial Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.2. North America Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
9.1.3. North America Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.4. North America Antibacterial Drugs Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
9.1.5. North America Antibacterial Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
9.1.5.1. U.S. Antibacterial Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.1.2. U.S. Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
9.1.5.1.3. U.S. Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Antibacterial Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.2.2. Canada Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
9.1.5.2.3. Canada Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Antibacterial Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.3.2. Mexico Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
9.1.5.3.3. Mexico Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Antibacterial Drugs Market Overview, By Countries, 2015 - 2028(USD Million)
10.1. Europe Antibacterial Drugs Market Overview, 2015 - 2028 (USD Million)
10.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.2. Europe Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
10.1.3. Europe Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
10.1.4. Europe Antibacterial Drugs Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
10.1.5. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2028 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.1.2. Germany Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.1.3. Germany Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.1.4. Other Segment
10.1.5.2. France
10.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.2.2. France Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.2.3. France Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.2.4. Other Segment
10.1.5.3. UK
10.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.3.2. UK Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.3.3. UK Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.3.4. Other Segment
10.1.5.4. Italy
10.1.5.4.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.4.2. Italy Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.4.3. Italy Antibacterial Drugs Market Overview, By Route of Administration 2015 - 2028(USD Million)
10.1.5.4.4. Other Segment
10.1.5.5. Spain
10.1.5.5.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.5.2. Spain Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.5.3. Spain Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.5.4. Other Segment
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Size and projections, 2015 – 2028
10.1.5.6.2. Rest of Europe Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
10.1.5.6.3. Rest of Europe Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
10.1.5.6.4. Other Segment
Chapter 11. Asia Pacific Antibacterial Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1. Asia Pacific Antibacterial Drugs Market Overview, 2015 - 2028 (USD Million)
11.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.2. Asia Pacific Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
11.1.3. Asia Pacific Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.4. Asia Pacific Antibacterial Drugs Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
11.1.5. Asia Pacific Antibacterial Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.1.2. India Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
11.1.5.1.3. India Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.5.1.4. Other Segment
11.1.5.2. China
11.1.5.2.1. Market Size and projections, 2015 - 2028(USD Million)
11.1.5.2.2. China Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
11.1.5.2.3. China Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.5.2.4. Other Segment
11.1.5.3. Japan
11.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.3.2. Japan Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
11.1.5.3.3. Japan Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028(USD Million)
11.1.5.3.4. Other Segment
11.1.5.4. South Korea
11.1.5.4.1. Market Size and projections, 2015 - 2028(USD Million)
11.1.5.4.2. South Korea Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
11.1.5.4.3. South Korea Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.5.4.4. Other Segment
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028(USD Million)
11.1.5.5.3. Rest of Asia Pacific Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
11.1.5.5.4. Other Segment
Chapter 12. Middle East & Africa Antibacterial Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1. Middle East & Africa Antibacterial Drugs Market Overview, 2015 - 2028 (USD Million)
12.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.2. Middle East & Africa Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
12.1.3. Middle East & Africa Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.4. Middle East & Africa Antibacterial Drugs Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
12.1.5. Middle East & Africa Antibacterial Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.1.2. GCC Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
12.1.5.1.3. GCC Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.5.1.4. Other Segment
12.1.5.2. South Africa
12.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.2.2. South Africa Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
12.1.5.2.3. South Africa Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.5.2.4. Other Segment
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
12.1.5.3.4. Other Segment
Chapter 13. South America Antibacterial Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
13.1. South America Antibacterial Drugs Market Overview, 2015 - 2028 (USD Million)
13.1.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.2. South America Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
13.1.3. South America Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.4. South America Antibacterial Drugs Market Overview, By Distribution Channel, 2015 - 2028 (USD Million)
13.1.5. South America Antibacterial Drugs Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.6.2. Brazil Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
13.1.6.3. Brazil Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.6.4. Other Segment
13.1.7. Argentina
13.1.7.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.7.2. Argentina Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
13.1.7.3. Argentina Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.7.4. Other Segment
13.1.8. Rest of South America
13.1.8.1. Market Size and projections, 2015 – 2028
13.1.8.2. Rest of South America Antibacterial Drugs Market Overview, By Drug Class, 2015 - 2028 (USD Million)
13.1.8.3. Rest of South America Antibacterial Drugs Market Overview, By Route of Administration, 2015 - 2028 (USD Million)
13.1.8.4. Other Segment
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2021
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Size development
Chapter 15. Key Vendor Analysis
15.1. Pfizer Inc.
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Drug Class Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Sanofi
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Drug Class Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. GlaxoSmithKline Plc.
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Drug Class Benchmarking
15.3.4. Recent initiatives
15.4. Allergen Plc.
15.5. Novartis Ag
15.6. AstraZeneca
15.7. Bayer AG
15.8. Others
Chapter 16. Antibacterial Drugs Market Cost Analysis
16.1. Antibacterial Drugs Market Key Offering Analysis
16.1.1. Key Offering
16.1.2. Price Trend of Key Drug Class
16.1.3. Key Suppliers
16.1.4. Labor Cost
Chapter 17. Industrial Chain, Sourcing Strategy and Downstream Buyers
17.1. Antibacterial Drugs Market Industrial Chain Analysis
17.2. Upstream Offering Sourcing
17.3. Raw Material Sources of Antibacterial Drugs Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Drug Class Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Drug Class Progress in Related Size
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Antibacterial Drugs Market, 2015-2028 (USD Million)
4. Biochemical Sensor requirement, by country, 2015-2028 (USD Million)
5. North America Antibacterial Drugs Market, By Drug Class, 2015-2028 (USD Million)
6. North America Antibacterial Drugs Market, By Route of Administration, 2015-2028 (USD Million)
7. North America Antibacterial Drugs Market, By Distribution Channel, 2015-2028 (USD Million)
8. Europe Antibacterial Drugs Market, By Drug Class, 2015-2028 (USD Million)
9. Europe Antibacterial Drugs Market, By Route of Administration, 2015-2028 (USD Million)
10. Europe Antibacterial Drugs Market, By Distribution Channel, 2015-2028 (USD Million)
11. Asia Pacific Antibacterial Drugs Market, By Drug Class, 2015-2028 (USD Million)
12. Asia Pacific Antibacterial Drugs Market, By Route of Administration, 2015-2028 (USD Million)
13. Asia Pacific Antibacterial Drugs Market, By Distribution Channel, 2015-2028 (USD Million)
14. Middle East & Africa Antibacterial Drugs Market, By Drug Class, 2015-2028 (USD Million)
15. Middle East & Africa Antibacterial Drugs Market, By Route of Administration, 2015-2028 (USD Million)
16. Middle East & Africa Antibacterial Drugs Market, By Distribution Channel, 2015-2028 (USD Million)
17. South America Antibacterial Drugs Market, By Drug Class, 2015-2028 (USD Million)
18. South America Antibacterial Drugs Market, By Route of Administration, 2015-2028 (USD Million)
19. South America Antibacterial Drugs Market, By Distribution Channel, 2015-2028 (USD Million)
20. Global Antibacterial Drugs Market, Company Market Share, 2020 - 2028 (%)
21. Pfizer Inc.: Drug Class Benchmarking
22. Pfizer Inc.: Financial Performance
23. Sanofi: Drug Class Benchmarking
24. Sanofi: Financial Performance
25. GlaxoSmithKline Plc.: Drug Class Benchmarking
26. GlaxoSmithKline Plc.: Financial Performance
27. Allergen Plc.: Drug Class Benchmarking
28. Allergen Plc.: Financial Performance
29. Novartis Ag: Drug Class Benchmarking
30. Novartis Ag: Financial Performance
31. AstraZeneca: Drug Class Benchmarking
32. AstraZeneca: Financial Performance
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Antibacterial Drugs Market share, By Drug Class, 2020 & 2028 (%)
10. Global Antibacterial Drugs Market share, by B-lactams, By Drug Class, 2015 - 2028 (USD Million)
11. Global Antibacterial Drugs Market share, by Quinolones, By Drug Class, 2015 - 2028 (USD Million)
12. Global Antibacterial Drugs Market share, by Macrolides, By Drug Class, 2015 - 2028 (USD Million)
13. Global Antibacterial Drugs Market share, by Tetracycline, By Drug Class, 2015 - 2028 (USD Million)
14. Global Antibacterial Drugs Market share, by Aminoglycoside, By Drug Class, 2015 - 2028 (USD Million)
15. Global Antibacterial Drugs Market share, by Others, By Drug Class, 2015 - 2028 (USD Million)
16. Global Antibacterial Drugs Market share, By Route of Administration, 2020 & 2028 (%)
17. Global Antibacterial Drugs Market share, by Enteral, By Route of Administration, 2015 - 2028 (USD Million)
18. Global Antibacterial Drugs Market share, by Parenteral, By Route of Administration, 2015 - 2028 (USD Million)
19. Global Antibacterial Drugs Market share, by Other, By Route of Administration, 2015 - 2028 (USD Million)
20. Global Antibacterial Drugs Market share, By Distribution Channel, 2020 & 2028 (%)
21. Global Antibacterial Drugs Market share, by Hospital Pharmacies, By Distribution Channel, 2015 - 2028 (USD Million)
22. Global Antibacterial Drugs Market share, by Drug Stores and Retail Pharmacies, By Distribution Channel, 2015 - 2028 (USD Million)
23. Global Antibacterial Drugs Market share, by Others, By Distribution Channel, 2015 - 2028 (USD Million)
24. Global Antibacterial Drugs Market share, by Region, 2020 & 2028 (%)
25. Global Antibacterial Drugs Market share, by Region, 2015 - 2028(USD Million)
26. North America Antibacterial Drugs Market, 2015 - 2028(USD Million)
27. North America Antibacterial Drugs Market share, by Countries, 2020 & 2028 (%)
28. U.S. Antibacterial Drugs Market, 2015 - 2028(USD Million)
29. Canada Antibacterial Drugs Market, 2015 - 2028(USD Million)
30. Mexico Antibacterial Drugs Market, 2015 - 2028(USD Million)
31. Europe Antibacterial Drugs Market, 2015 - 2028(USD Million)
32. Europe Antibacterial Drugs Market share, by Countries, 2020 & 2028 (%)
33. Spain Antibacterial Drugs Market, 2015 - 2028(USD Million)
34. UK Antibacterial Drugs Market, 2015 - 2028(USD Million)
35. Italy Antibacterial Drugs Market, 2015 - 2028(USD Million)
36. Germany Antibacterial Drugs Market, 2015 - 2028(USD Million)
37. France Antibacterial Drugs Market, 2015 - 2028(USD Million)
38. Rest of Europe Antibacterial Drugs Market, 2015 - 2028(USD Million)
39. Asia-Pacific Antibacterial Drugs Market, 2015 - 2028(USD Million)
40. Asia-Pacific Antibacterial Drugs Market share, by Countries, 2020 & 2028 (%)
41. China Antibacterial Drugs Market, 2015 - 2028(USD Million)
42. India Antibacterial Drugs Market, 2015 - 2028(USD Million)
43. Australia Antibacterial Drugs Market, 2015 - 2028(USD Million)
44. Japan Antibacterial Drugs Market, 2015 - 2028(USD Million)
45. Rest of Asia-Pacific Antibacterial Drugs Market, 2015 - 2028(USD Million)
46. Middle East & Africa Antibacterial Drugs Market, 2015 - 2028(USD Million)
47. Middle East & Africa Antibacterial Drugs Market share, by Countries, 2020 & 2028 (%)
48. GCC Antibacterial Drugs Market, 2015 - 2028(USD Million)
49. South Africa Antibacterial Drugs Market, 2015 - 2028(USD Million)
50. Rest Of Middle East & Africa Antibacterial Drugs Market, 2015 - 2028(USD Million)
51. South America Antibacterial Drugs Market, 2015 - 2028(USD Million)
52. Brazil Antibacterial Drugs Market, 2015 - 2028(USD Million)
53. Mexico Antibacterial Drugs Market, 2015 - 2028(USD Million)
54. Argentina Antibacterial Drugs Market, 2015 - 2028(USD Million)
55. Rest Of South America Antibacterial Drugs Market, 2015 - 2028(USD Million)
The Leading Key Players in Global Antibacterial Drugs Market
